Hyo Song Kim, MD
Department of Internal Medicine, Yonsei University
Dr. Kim is highly accomplished medical/clinical/developmental expert with over 10 year-experience. She has extensive experience managing medical and new drug development. During past years, personalizing treatment of metastatic solid tumors has been her primary research goal with emphasis on rare cancer, especially desmoid tumor. She also served as principle investigator of several sponsor-initiated and investigator-initiated clinical trials for desmoid tumor.